Join Us!

Members shall be any national non-profit organization interested in women’s health research. Organizations may have more than one representative participate in WFRC meetings and designated to receive WFRC communications and updates. New applications for organizational membership will be vetted and approved by the co-chairs.

Official Representative. Each member of the WFRC shall have an official representative who shall be designated by the member organization. The official representative will serve as the member organization’s primary contact for WFRC business. WFRC’s Washington representative shall be responsible for the record keeping of membership and meetings.

Voting. Each dues paying member organization shall be entitled to one vote, which will be cast by each organization’s designated official voting representative. All votes that require approval will require a simple majority vote. At all WFRC meetings, a majority of the voting member organizations shall constitute a quorum for the transaction of business. WFRC’s Washington representative shall be responsible for updating each voting member’s voting representative annually; the same individual may serve as both the official and voting representatives for voting members organizations.

Meetings. The WFRC will meet at least once per quarter. These meetings may be held virtually.

Warner K. Huh

Warner K. Huh, MD, MSHA is Chair of the Department of Obstetrics and Gynecology and holds the Charles E. Flowers, Jr. Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB). He is also Professor in the Department of Surgery and Professor in the Department of Epidemiology in the UAB School of Public Health. He was previously the Division Director of Gynecologic Oncology, Vice Chair of Gynecology, and Chief Medical Officer of the UAB Cancer Service Line/O’Neal Comprehensive Cancer Center. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He has authored or co-authored over 300 articles in journals including The New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute Cancer, Clinical Cancer Research, Gynecologic Oncology, Obstetrics & Gynecology, and the American Journal of Obstetrics & Gynecology (h-index: 70). Dr. Huh serves as co-PI (MPI) of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence (SPORE) program (2P50CA098252-06A1) – one of the most enduring SPORE programs in the NCI. Further, he is PI on a cervical cancer prevention R01 grant through the NCI (5R01CA279021). Dr. Huh serves as a Deputy Editor of Gynecologic Oncology and serves as an Associate Editor of The Journal of Lower Genital Tract Disease. He is on the steering committee for the ASCCP treatment guidelines and was co-chair of the ASCCP colposcopy standards effort. He is Past President of the Society of Gynecologic Oncology (SGO) and ASCCP. He is currently serves on the American Board of Obstetrics and Gynecology (ABOG) Division of Gynecologic Oncology. He recently completed the Executive Master of Science in Health Administration (MSHA) Program at UAB (2022-2024). He co-leads OPERATION WIPEOUT- the only state-based cervical cancer elimination effort in the United States.